August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Reports Q4 revenue $2.6M, consensus $3.35M.”With commercial preparations underway, we believe we are well positioned to launch TNX-102 SL for ...

Various showbiz personalities expressed their support for former host-actress Kris Aquino who praised her youngest ...

The blues and the jitters are very common among people battling chronic pain, a new evidence review says.About 40% of ...

A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models.

Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...

New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...

Developing myalgic encephalomyelitis/chronic fatigue syndrome is significantly more likely after a case of COVID-19, an ...

Certain terpenes found in moderate to high levels in Cannabis sativa successfully relieved fibromyalgia and post-surgical pain in mouse models. | Cannabis Sciences ...

Of all the treatments for fibromyalgia (FMS) and chronic fatigue syndrome (ME/CFS), antidepressants may be the hardest for people to understand. It's common for people to be confused about why these ...

Objectives Fibromyalgia is commonly considered a stress-related chronic pain disorder, and daily stressors are known triggers. However, the relation between stress and pain development remains poorly ...